Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA’s Inspection Volume Projected To Return To Normal Levels In FY 2022 As Backlog Looms
Jun 02 2021
•
By
Derrick Gingery
The FDA requested a 7.9% increase in its overall budget, including a 9.8% increase in budget authority. • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA
More from Agency Leadership